Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.41 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.33 |
| ▸ | MPL | P40238 | 1/20 | 0.33 |
| ▸ | CTRC | Q99895 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12189771 | 0.84 | FUT8 (0.52) | FUT8P2RX7P2RX2MEN1THRB | |
| SCHEMBL12172983 | 0.77 | FUT8 (0.35) | FUT8CTRB1MPLCTRC | |
| SCHEMBL18218148 | 0.75 | FUT8 (0.59) | FUT8CTRB1P2RX7P2RX2MPL | |
| SCHEMBL13100747 | 0.74 | KMT2A (0.43) | FUT8CTRB1MPLCTRCMEN1 | |
| SCHEMBL12974350 | 0.73 | FUT8 (0.65) | FUT8MEN1THRBKMT2A | |
| SCHEMBL18218147 | 0.72 | FUT8 (0.56) | FUT8CTRB1P2RX7P2RX2MPL | |
| SCHEMBL12189773 | 0.70 | FUT8 (0.46) | FUT8P2RX7P2RX2MPLCTRC | |
| SCHEMBL12974423 | 0.69 | ENPP2 (0.48) | FUT8P2RX7P2RX2MEN1THRB | |
| SCHEMBL10039850 | 0.68 | FUT8 (0.42) | FUT8CTRB1MEN1THRBKMT2A | |
| SCHEMBL15362445 | 0.68 | FUT8 (0.58) | FUT8CTRB1MPLCTRCMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | FUT8 769/4885CTRB1 3580/4885P2RX7 2704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.